ZOM
Income statement / Annual
Last year (2024), Zomedica Corp.'s total revenue was $25.19 M,
an increase of 33.05% from the previous year.
In 2024, Zomedica Corp.'s net income was -$34.53 M.
See Zomedica Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
02/28/2015 |
| Operating Revenue |
$25.19 M
|
$18.93 M
|
$4.13 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$7.87 M |
$5.28 M |
$1.08 M |
$530,020.00 |
$787,613.00 |
$205,767.00 |
$92,410.00 |
$45,821.00 |
$0.00 |
$0.00 |
| Gross Profit |
$17.32 M |
$13.65 M |
$3.05 M |
-$530,020.00 |
-$787,613.00 |
-$205,767.00 |
-$92,410.00 |
-$45,821.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0.69 |
0.72 |
0.74 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.74 M
|
$2.58 M
|
$1.67 M
|
$8.04 M
|
$10.35 M
|
$10.32 M
|
$2.75 M
|
$1.52 M
|
$758,054.00
|
$0.00
|
| General & Administrative
Expenses |
$29.03 M
|
$22.93 M
|
$0.00
|
$7.93 M
|
$8.18 M
|
$5.83 M
|
$5.08 M
|
$4.24 M
|
$1.43 M
|
$42,409.00
|
| Selling & Marketing
Expenses |
$14.14 M
|
$9.88 M
|
$0.00
|
$261,911.00
|
$471,887.00
|
$225,890.00
|
$164,250.00
|
$194,187.00
|
$143,473.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$43.17 M
|
$33.00 M
|
$22.75 M
|
$8.19 M
|
$8.65 M
|
$6.06 M
|
$5.24 M
|
$4.43 M
|
$1.57 M
|
$42,409.00
|
| Other Expenses |
$0.00 |
-$7,000.00 |
$6,000.00 |
$530,020.00 |
$787,613.00 |
$205,767.00 |
$92,410.00 |
$45,821.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$48.91 M |
$35.58 M |
$24.43 M |
$16.76 M |
$19.78 M |
$16.58 M |
$8.08 M |
$6.00 M |
$2.28 M |
$42,409.00 |
| Cost And Expenses |
$56.78 M |
$40.85 M |
$25.51 M |
$16.76 M |
$19.78 M |
$16.58 M |
$8.08 M |
$6.00 M |
$2.28 M |
$42,409.00 |
| Interest Income |
$5.46 M |
$2.70 M |
$357,447.00 |
$32,859.00 |
$18,338.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$175,000.00 |
$1,000.00 |
$6,054.00 |
$732.00 |
$18,338.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$6.30 M
|
$4.04 M
|
$1.14 M
|
$530,020.00
|
$787,613.00
|
$205,767.00
|
$92,410.00
|
$45,821.00
|
$9,053.00
|
$0.00
|
| EBITDA |
-$29.39 M
|
-$15.34 M
|
-$19.57 M
|
-$16.38 M
|
-$19.00 M
|
-$16.44 M
|
-$7.97 M
|
-$5.97 M
|
-$2.28 M
|
-$42,409.90
|
| EBITDA Ratio |
-1.17 |
-0.8 |
-4.8 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-1.25
|
-1.16
|
-5.17
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$4.27 M
|
$2.54 M
|
$657,776.00
|
-$146,806.00
|
$273.00
|
-$68,441.00
|
$18,977.00
|
$258,058.00
|
$7,439.00
|
$0.00
|
| Income Before Tax |
-$35.86 M |
-$19.38 M |
-$20.72 M |
-$16.91 M |
-$19.78 M |
-$16.65 M |
-$8.07 M |
-$6.01 M |
-$2.28 M |
-$42,409.90 |
| Income Before Tax Ratio
|
-1.42
|
-1.02
|
-5.01
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$1.33 M |
-$2.37 M |
-$2.33 M |
$9,333.00 |
$38,075.00 |
$136,882.00 |
-$18,978.00 |
$28,592.00 |
$0.00 |
$0.00 |
| Net Income |
-$34.53 M |
-$17.02 M |
-$18.38 M |
-$16.92 M |
-$19.82 M |
-$16.65 M |
-$8.07 M |
-$6.01 M |
-$2.28 M |
-$42,409.90 |
| Net Income Ratio |
-1.37 |
-0.9 |
-4.45 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.0352 |
-0.0174 |
-0.0192 |
-0.0464 |
-0.19 |
-0.18 |
-0.0923 |
-0.075 |
-0.0493 |
-0.0424 |
| EPS Diluted |
-0.0352 |
-0.0174 |
-0.0192 |
-0.0464 |
-0.19 |
-0.18 |
-0.0923 |
-0.075 |
-0.0493 |
-0.0424 |
| Weighted Average Shares
Out |
$979.95 M
|
$979.92 M
|
$956.53 M
|
$364.44 M
|
$106.30 M
|
$92.49 M
|
$87.40 M
|
$80.16 M
|
$46.23 M
|
$1.00 M
|
| Weighted Average Shares
Out Diluted |
$979.95 M
|
$979.92 M
|
$956.53 M
|
$364.44 M
|
$106.30 M
|
$93.44 M
|
$87.40 M
|
$80.16 M
|
$46.23 M
|
$1.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
